BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32075687)

  • 1. Circulating 27-hydroxycholesterol and breast cancer tissue expression of CYP27A1, CYP7B1, LXR-β, and ERβ: results from the EPIC-Heidelberg cohort.
    Le Cornet C; Walter B; Sookthai D; Johnson TS; Kühn T; Herpel E; Kaaks R; Fortner RT
    Breast Cancer Res; 2020 Feb; 22(1):23. PubMed ID: 32075687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating 27-Hydroxycholesterol and Breast Cancer Risk: Results From the EPIC-Heidelberg Cohort.
    Lu DL; Le Cornet C; Sookthai D; Johnson TS; Kaaks R; Fortner RT
    J Natl Cancer Inst; 2019 Apr; 111(4):365-371. PubMed ID: 30016454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer.
    Kimbung S; Chang CY; Bendahl PO; Dubois L; Thompson JW; McDonnell DP; Borgquist S
    Endocr Relat Cancer; 2017 Jul; 24(7):339-349. PubMed ID: 28442559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between lifestyle, dietary, reproductive, and anthropometric factors and circulating 27-hydroxycholesterol in EPIC-Heidelberg.
    Le Cornet C; Johnson TS; Lu DL; Kaaks R; Fortner RT
    Cancer Causes Control; 2020 Feb; 31(2):181-192. PubMed ID: 31938951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients.
    Kimbung S; Inasu M; Stålhammar T; Nodin B; Elebro K; Tryggvadottir H; Ygland Rödström M; Jirström K; Isaksson K; Jernström H; Borgquist S
    Breast Cancer Res; 2020 Nov; 22(1):123. PubMed ID: 33176848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D supplementation decreases serum 27-hydroxycholesterol in a pilot breast cancer trial.
    Going CC; Alexandrova L; Lau K; Yeh CY; Feldman D; Pitteri SJ
    Breast Cancer Res Treat; 2018 Feb; 167(3):797-802. PubMed ID: 29116467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology.
    Nelson ER; Wardell SE; Jasper JS; Park S; Suchindran S; Howe MK; Carver NJ; Pillai RV; Sullivan PM; Sondhi V; Umetani M; Geradts J; McDonnell DP
    Science; 2013 Nov; 342(6162):1094-8. PubMed ID: 24288332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the regulatory importance of 27-hydroxycholesterol in mouse liver.
    Heverin M; Ali Z; Olin M; Tillander V; Joibari MM; Makoveichuk E; Leitersdorf E; Warner M; Olivercrona G; Gustafsson JÅ; Björkhem I
    J Steroid Biochem Mol Biol; 2017 May; 169():10-21. PubMed ID: 26851362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression.
    Ma L; Wang L; Nelson AT; Han C; He S; Henn MA; Menon K; Chen JJ; Baek AE; Vardanyan A; Shahoei SH; Park S; Shapiro DJ; Nanjappa SG; Nelson ER
    Cancer Lett; 2020 Nov; 493():266-283. PubMed ID: 32861706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth.
    Wu Q; Ishikawa T; Sirianni R; Tang H; McDonald JG; Yuhanna IS; Thompson B; Girard L; Mineo C; Brekken RA; Umetani M; Euhus DM; Xie Y; Shaul PW
    Cell Rep; 2013 Nov; 5(3):637-45. PubMed ID: 24210818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of 27-hydroxycholesterol and its metabolism in cancer progression: Human studies.
    Biasi F; Leoni V; Gamba P; Sassi K; Lizard G; Poli G
    Biochem Pharmacol; 2022 Feb; 196():114618. PubMed ID: 34023292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased 27-hydroxycholesterol production during luteolysis may mediate the progressive decline in progesterone secretion.
    Xu Y; Hutchison SM; Hernández-Ledezma JJ; Bogan RL
    Mol Hum Reprod; 2018 Jan; 24(1):2-13. PubMed ID: 29177442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Our evolving understanding of how 27-hydroxycholesterol influences cancer.
    Ma L; Cho W; Nelson ER
    Biochem Pharmacol; 2022 Feb; 196():114621. PubMed ID: 34043965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha.
    Umetani M; Ghosh P; Ishikawa T; Umetani J; Ahmed M; Mineo C; Shaul PW
    Cell Metab; 2014 Jul; 20(1):172-82. PubMed ID: 24954418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating 27-hydroxycholesterol, lipids, and steroid hormones in breast cancer risk: a nested case-control study of the Multiethnic Cohort Study.
    DeRouen MC; Yang J; Li Y; Franke AA; Tome AN; White KK; Hernandez BY; Shvetsov Y; Setiawan V; Wu AH; Wilkens LR; Le Marchand L; Loo LWM; Cheng I
    Breast Cancer Res; 2023 Aug; 25(1):95. PubMed ID: 37580793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen Receptor Beta-Mediated Modulation of Lung Cancer Cell Proliferation by 27-Hydroxycholesterol.
    Hiramitsu S; Ishikawa T; Lee WR; Khan T; Crumbley C; Khwaja N; Zamanian F; Asghari A; Sen M; Zhang Y; Hawse JR; Minna JD; Umetani M
    Front Endocrinol (Lausanne); 2018; 9():470. PubMed ID: 30190703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interaction among peroxisome proliferators-activated receptor alpha, cytochrome P450 oxysterol 7α-hydroxylase and estrogen receptor and its association with intrahepatic cholestasis in pregnant rats].
    Shi QY; Lin YG; Zhou X; Lin YQ; Yan S
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jun; 45(6):440-4. PubMed ID: 21029595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host CYP27A1 expression is essential for ovarian cancer progression.
    He S; Ma L; Baek AE; Vardanyan A; Vembar V; Chen JJ; Nelson AT; Burdette JE; Nelson ER
    Endocr Relat Cancer; 2019 Jul; 26(7):659-675. PubMed ID: 31048561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of 27-hydroxycholesterol on endometrial cancer proliferation.
    Gibson DA; Collins F; Cousins FL; Esnal Zufiaurre A; Saunders PTK
    Endocr Relat Cancer; 2018 Apr; 25(4):381-391. PubMed ID: 29371332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of 27-hydroxycholesterol on the progression of non-small cell lung cancer via the estrogen receptor.
    Takada I; Miyazaki T; Goto Y; Kanzawa H; Matsubara T; Namikawa-Kanai H; Shigefuku S; Ono S; Nakajima E; Morishita Y; Honda A; Furukawa K; Ikeda N
    Am J Cancer Res; 2022; 12(9):4241-4253. PubMed ID: 36225627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.